D. Vincenti

Autologous hematopoietic stem cell transplantation has better outcomes than conventional therapies in patients with rapidly progressive systemic sclerosis

C. Vitali, A. Cortelezzi, T. Montemurro, 2017, Bone Marrow Transplantation.

Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients

M. Baldini, A. Orsatti, A. Cortelezzi, 2018, Annals of Hematology.

Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs

P. Chiusolo, F. Tambaro, A. Prete, 2020, Annals of Hematology.

Unilateral exophthalmos and multiple subcutaneous nodules as a result of extranodal marginal zone lymphoma.

L. Baldini, A. Ferrario, M. Goldaniga, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy

I. Isaias, R. Benti, G. Marotta, 2021, Frontiers in Neuroscience.

Low‐dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long‐term outcome from a single center experience

D. Rossi, G. Gaidano, A. Cortelezzi, 2015, American journal of hematology.

Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial

R. Foà, M. Gobbi, M. Vignetti, 2014, Leukemia.

Quality of Life Before and After Transplantation in Solid Organ Recipients Referred to the North Italy Transplant program (NITp): A Cross-sectional Study.

M. Cardillo, S. Passamonti, F. Poli, 2019, Transplantation proceedings.

Haploidentical Hematopoietic Stem Cell Transplant Complicated by Atypical Hemolytic Uremic Syndrome and Kidney Transplant From the Same Donor With No Immunosuppression but C5 Inhibition

G. Ardissino, P. Messa, F. Ciceri, 2019, Transplantation.

In vitro activity of human chorionic gonadotropin (hCG)--doxorubicin conjugates against ovarian cancer cells.

W. Jäger, E. Beck, P. Licht, 2000, Anticancer research.